1339 Systemically administered onco-selective mRNA LNP achieves tumor regression and improves overall survival, as monotherapy

• Manfred Kraus,
• Aniela Jakubowski,
• Yulia Rybakova,
• Nicole Lessard,
• Rudy Christmas,
• Tom Addison,
• Leona Lee,
• Jieni Xu,
• Mark Krimmer,
• Cafer Ozdemir,
• Burak Yilmaz,
• Yusuf Erkul,
• Isaak Mueller

Affiliations

Manfred Kraus

1Kernal Biologics, Cambridge, MA, USA

Aniela Jakubowski

Elicio Therapeutics, Boston, MA, USA

Yulia Rybakova

1Kernal Biologics, Cambridge, MA, USA

Nicole Lessard

1Kernal Biologics, Cambridge, MA, USA

Rudy Christmas

1Kernal Biologics, Cambridge, MA, USA

Tom Addison

1Kernal Biologics, Cambridge, MA, USA

Leona Lee

1Kernal Biologics, Cambridge, MA, USA

Jieni Xu

1Kernal Biologics, Cambridge, MA, USA

Mark Krimmer

1Kernal Biologics, Cambridge, MA, USA

Cafer Ozdemir

1Kernal Biologics, Cambridge, MA, USA

Burak Yilmaz

1Kernal Biologics, Cambridge, MA, USA

Yusuf Erkul

1Kernal Biologics, Cambridge, MA, USA

Isaak Mueller

Kernal Biologics, Cambridge, MA, USA